Tag

Tag: Newron

08/05/2020 3 mins

Phase III Failure Sinks Drug for Rare Neurological Disorder

11/01/2018 2 mins

Standardization in Orphan Drug Development

07/11/2017 2 mins

British Researchers Find Thought Police to Treat Neurological Disorders

10/10/2017 6 mins

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

26/09/2017 1 min

After Major Parkinson’s Approval, Italian Biotech Boosts its Research Pipeline

12/05/2017 2 mins

UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

20/04/2017 2 mins

Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years

31/03/2017 1 min

More News! Results from AB Science and Newron in MS & Schizophrenia

21/02/2017 1 min

Infographic: The Biggest Biotech Company in Each European Country

13/01/2017 1 min

More News! Trump targets Pharma, €1B Deal for Ipsen, & a Hep B update

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.

AI Drug Discovery Firm Exscientia Closes €54M Series C

Argenx Follows up Phase III Success with Giant €785M Global Offering